Filing Flows › ELI Lilly (LLY) › How it makes money
How ELI Lilly (LLY) makes money
ELI Lilly (LLY) made $24.4B of revenue in the third quarter 2026 (Q3 2026), +40% from a year earlier. Net product revenue brought in $22.7B (93%); Other oncology brought in $1.1B (4%); Other immunology brought in $579M (2%). Of every dollar of revenue, 34¢ was left as operating profit, 26¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Net product revenue | $22.7B | 93.2% | — | +42% |
| ↳ Mounjaro | $10.7B | 44.0% | — | +65% |
| ↳ Zepbound | $5.4B | 22.0% | — | +49% |
| ↳ Jardiance | $1.6B | 6.5% | — | +65% |
| ↳ Verzenio | $1.5B | 6.2% | — | +3% |
| ↳ Immunology | $1.4B | 5.9% | — | +5% |
| ↳ Other cardiometabolic health | $1.2B | 5.0% | — | +13% |
| ↳ Trulicity | $904M | 3.7% | — | -14% |
| Other oncology | $1.1B | 4.5% | — | +16% |
| Other immunology | $579M | 2.4% | — | +26% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $24.4B | 100.0% |
| Operating profit | $8.4B | 34.5% |
| Income tax | $2.0B | 8.0% |
| Net earnings | $6.5B | 26.5% |
| Operating cash flow | $11.4B | 46.8% |
| Free cash flow | $8.2B | 33.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23.0B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
From ELI Lilly's 10-Q filed Oct 29, 2026 (on EDGAR).
Questions
How does ELI Lilly make money?
ELI Lilly (LLY) made $24.4B of revenue in the third quarter 2026 (Q3 2026), +40% from a year earlier. Net product revenue brought in $22.7B (93%); Other oncology brought in $1.1B (4%); Other immunology brought in $579M (2%). Of every dollar of revenue, 34¢ was left as operating profit, 26¢ was left as net earnings.
What is ELI Lilly's biggest business?
Net product revenue: $22.7B in the third quarter 2026, 93% of revenue, +42% from a year earlier.
What is ELI Lilly's profit margin?
Net earnings were $6.5B, 26.5% of revenue, in the third quarter 2026; the operating margin was 34.5%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.